UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000028749 |
|---|---|
| Receipt number | R000032844 |
| Scientific Title | A phase II study of perioperative capecitabine plus Oxaliplatin(CapeOx) therapy for advanced gastric cancer with multiple lymph node metastases (OGSG 1701) |
| Date of disclosure of the study information | 2017/09/01 |
| Last modified on | 2022/08/28 17:59:57 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/08/20 01:44:47 | ||
| 2 | Update | 2017/08/20 02:10:18 | Key exclusion criteria |
|
| 3 | Update | 2017/08/20 02:28:41 | Address |
|
| 4 | Update | 2017/08/21 22:23:09 | Email Name of person sending information |
|
| 5 | Update | 2017/08/22 22:00:17 | Public title Acronym |
|
| 6 | Update | 2017/08/22 22:03:47 | Narrative objectives1 Narrative objectives1 Primary outcomes Key secondary outcomes |
|
| 7 | Update | 2017/08/22 22:19:49 | Division name Organization |
|
| 8 | Update | 2017/09/29 01:17:02 | Recruitment status |
|
| 9 | Update | 2018/02/20 23:49:24 | Email |
|
| 10 | Update | 2018/08/01 06:44:57 | UMIN ID1 |
|
| 11 | Update | 2018/08/22 21:37:36 | Institutions |
|
| 12 | Update | 2018/08/22 21:38:34 | Anticipated trial start date |
|
| 13 | Update | 2019/02/20 22:58:49 | Institutions |
|
| 14 | Update | 2020/01/05 21:31:47 | Date of IRB |
|
| 15 | Update | 2022/08/28 17:55:51 | Recruitment status Last follow-up date |
|
| 16 | Update | 2022/08/28 17:59:57 | Number of participants that the trial has enrolled |
